rss
Br J Ophthalmol 2009;93:557-558 doi:10.1136/bjo.2008.148148
  • Letter
    • PostScript

Trabecular meshwork in neovascular glaucoma eyes after the intravitreal injection of bevacizumab

  1. T Kubota1,
  2. R Aoki1,
  3. Y Harada1,
  4. N Tou1,
  5. Y Kohno1,
  6. A Tawara1,
  7. H Satoh2,
  8. S Shimajiri2
  1. 1
    Department of Ophthalmology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan
  2. 2
    Department of Surgical Pathology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu, Japan
  1. Dr T Kubota, Department of Ophthalmology, School of Medicine, University of Occupational and Environmental Health, Japan, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu 807-8555, Japan; tkubota{at}med.uoeh-u.ac.jp
  • Accepted 26 October 2008

Neovascular glaucoma (NVG) is a severe consequence of ocular ischaemic disease. The mechanism of intraocular pressure (IOP) elevation is considered to be the increased permeability of the newly formed vessels,1 angle closure by the peripheral anterior synechia and intertrabecular neovascular tissue.2 3 The intravitreal injection of bevacizumab (IVB) was reported to be effective in the regression of new vessels.4 This injection may provide us with sufficient time to treat these patients with retinal photocoagulation. In addition, it may also be used as an adjunctive therapy for a mitomycin C (MMC) trabeculectomy to treat NVG. It remains to be elucidated as to how bevacizumab exerts its effects on the neovascular tissue in NVG. This study was carried out to examine the trabecular meshwork of eyes with NVG following the IVB.

A dose of 1.25 mg (0.05 ml) of IVB (Avastin 100 mg/4 ml, Roche, Reinach, Switzerland) was given in the superotemporal quadrant 4 mm posterior to the limbus of the affected eyes of three patients. The underlying diseases …

This Article

Services

  1. Request permissions

Responses

  1. Submit a response
  2. No responses published

Social bookmarking

Register for free content


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
View free sample issue >>

Free archive
The full back archive is now available for BJO. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
Register to access the free archive >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.